Bills › 2021–22 › SB 5723
BILL · 2021–22 SESSION · LATEST VERSION SSB 5723
SB 5723: Diversity in clinical trials
Concerning improving diversity in clinical trials.
Summary
Directs the Washington State Review Board to establish a program to encourage diversity in clinical trials for drugs and medical devices for underrepresented demographic groups. Requires state entities conducting clinical trials of drugs or medical devices to adopt policies for identifying and recruiting members of underrepresented demographic groups to participate in clinical trials.
From the Substitute House Bill Report (SSB 5723), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · passed Senate, stalled in House
IntroducedJan 10, 2022
Out of committeeFeb 7, 2022
Passed SenateFeb 14, 2022
Passed Housestopped here
Governor
Law
Introduced January 10, 2022 in the Senate
Last action March 10, 2022
Budget Has a fiscal note
Versions SB 5723, SSB 5723
Sponsors (3)
Votes (1)
History (29)
Official bill page & text ↗
AN ACT Relating to improving diversity in clinical trials;
Votes
Senate · 3rd Reading & Final Passage
Passed February 14, 2022
Version voted on: SSB 5723
48 Yea
0 Nay
0 Absent
1 Excused
Party Yea Nay Absent Excused
Democrat 28 0 0 1
Republican 20 0 0 0
How each member voted
History
Mar 10, 2022 By resolution, returned to Senate Rules Committee for third reading. (SSB 5723)
Feb 24, 2022 Referred to Appropriations. (SSB 5723)
Feb 23, 2022 HCW - Majority; do pass. (SSB 5723)
Feb 23, 2022 HCW - Executive action taken by committee. (SSB 5723)
Feb 16, 2022 First reading, referred to Health Care & Wellness. (SSB 5723)
Feb 14, 2022 Third reading, passed; yeas, 48; nays, 0; absent, 0; excused, 1. (SSB 5723)
Feb 14, 2022 Rules suspended. Placed on Third Reading. (SSB 5723)
Feb 14, 2022 1st substitute bill substituted. (SSB 5723)
Feb 14, 2022 1st substitute bill substituted.
Feb 11, 2022 Placed on second reading by Rules Committee. (SSB 5723)
Feb 11, 2022 Placed on second reading by Rules Committee.
Feb 7, 2022 Passed to Rules Committee for second reading. (SSB 5723)
Feb 7, 2022 Minority; without recommendation. (SSB 5723)
Feb 7, 2022 WM - Majority; do pass 1st substitute bill proposed by Health & Long Term Care. (SSB 5723)
Feb 7, 2022 WM - Majority; do pass 1st substitute bill proposed by Health & Long Term Care.
Feb 7, 2022 Minority; without recommendation.
Feb 7, 2022 Passed to Rules Committee for second reading.
Jan 31, 2022 Referred to Ways & Means. (SSB 5723)
Jan 31, 2022 Referred to Ways & Means.
Jan 28, 2022 HLTC - Majority; 1st substitute bill be substituted, do pass. (SSB 5723)
Jan 28, 2022 Minority; do not pass. (SSB 5723)
Jan 28, 2022 And refer to Ways & Means. (SSB 5723)
Jan 28, 2022 Minority; without recommendation. (SSB 5723)
Jan 28, 2022 Minority; without recommendation.
Jan 28, 2022 And refer to Ways & Means.
Jan 28, 2022 Minority; do not pass.
Jan 28, 2022 HLTC - Majority; 1st substitute bill be substituted, do pass.
Jan 10, 2022 First reading, referred to Health & Long Term Care.
Jan 6, 2022 Prefiled for introduction.
SB 5723 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
Report wrong or missing information on this page